Latest News about IONS
Recent news which mentions IONS
7 Best Biotech Stocks to Buy in July 2022
July 08, 2022
From InvestorPlace
Cathie Wood's Ark Invest Sheds $35M In 3D Printing Company Stratasys — What It Bought Instead
July 06, 2022
From Benzinga
EXCLUSIVE: Has Biotech Bottomed? NYSE Executive Floor Director Says Biogen And These 3 Stocks Look Poised To Outperform
June 30, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
5 Cathie Wood Stocks to Buy in June
June 09, 2022
From InvestorPlace
Cathie Wood Is Selling Gene Editing Stocks. Here’s Why.
June 02, 2022
Tags
Market News
Today's Market
NYSEARCA:ARKK,NYSEARCA:ARKG,NASDAQ:IONS,NASDAQ:BNR,NYSE:DNA,NASDAQ:EDIT
From InvestorPlace
From Benzinga
7 Potential Biotech Stocks Buyout Targets in 2022
April 21, 2022
From InvestorPlace
Ionis Pharma - AstraZeneca Antisense Medicine Met Its Primary, Secondary Goals To Lower Cholesterol
April 04, 2022
From Benzinga
From Benzinga
Why Cramer Likes Ferguson And Stanley Black & Decker
March 25, 2022
From Benzinga
This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst
March 22, 2022
From MarketWatch
Ionis Pharma Announces Publication Of Positive Donidalorsen Data For Angioedema Attacks
March 17, 2022
Tickers
IONS
From Benzinga
Benzinga's Daily Brief On Trending Tickers For March 11, 2022: Tesla, DTE Energy, Amazon And More
March 11, 2022
From Benzinga
Benzinga's Daily Brief On Trending Tickers For March 2, 2022: VanEck Russia ETF, AMC Entertainment, SoFi Technologies And More
March 02, 2022
From Benzinga
From Benzinga
Benzinga's Daily Brief On Trending Tickers For Feb. 25, 2022: GameStop, Tesla, AMD And More
February 25, 2022
From Benzinga
Benzinga's Daily Brief On Trending Tickers For Feb. 23, 2022: Palantir, GameStop, Tesla, And More
February 23, 2022
From Benzinga
Benzinga's Daily Brief On Trending Tickers For Feb. 22, 2022: Tesla, GameStop, Lexicon And More
February 22, 2022
From Benzinga
2 Unstoppable Growth-Oriented ETFs To Hold for the Long Haul
February 17, 2022
From Motley Fool
Why Investors Aren't Worried About Pfizer's Latest Failure
February 15, 2022
From Motley Fool
What 5 Analyst Ratings Have To Say About Ionis Pharmaceuticals
February 01, 2022
Tickers
IONS
From Benzinga
BofA Downgrades Ionis After Vupanorsen Setback: Are There Upcoming Catalysts That Can Help The Stock?
February 01, 2022
Tickers
IONS
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.